Navigation Links
Singapore To Offer More Patients Access To Chronic Disease Management Programs

Singapore will make every effort to include as many patients in the chronic disease management programs in the country, //according to Minister for Health Khaw Boon Wan who was addressing he third National Disease Management Conference.

"That chronic diseases are major causes of death and human suffering remains a fact as in the past," Khaw said, adding that prompt treatment could be an effective tool in such circumstances. To help patients manage the cost associated with chronic diseases, Singapore will allow them to opt out of their Medisave accounts to co-pay chronic disease management programs.

Khaw said that such measures would allow people to take charge of their own health and keep the doctors updated with their progress in managing the disease. A Disease Management Advisory Committee of Experts has also been set up and this committee will also monitor the management programs.

It is estimated that about 1/4th of Singapore's 4 million population is affected by chronic diseases like diabetes mellitus, hypertension, hyperlipidemia and stroke.

Page: 1

Related medicine news :

1. Death Of Singaporean Woman After Mysterious Illness
2. Singapore Government to Raise Fund For HIV Treatment
3. HIV Positive Men in Singapore Exposed
4. Singapore’s Healthcare To Outsource To Indian Firm For Faster X-Ray Result
5. Singapores AVA Advocates "Bio-Segregation" To Combat Bird Flu
6. Duck a Flu? - Singapore Embargoes Duck Imports from Malaysia
7. Indonesian Traveler Tests Negative For Bird Flu, Singapore Safe
8. 785 HFMD Cases In Singapore: Schools May Be Closed
9. Strained Economic Agreement Between Singapore And India
10. WHO Praises Singapore and Vietnam but Slams China With Respect To Tackling SARS
11. Singapore, India To Do Joint Research On Oral And Throat Cancers
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: